{"id":23828,"date":"2012-11-02T12:51:17","date_gmt":"2012-11-02T18:51:17","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=23828"},"modified":"2018-04-14T02:08:37","modified_gmt":"2018-04-14T07:08:37","slug":"23828","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/zh\/23828\/","title":{"rendered":"2012 \u5e74 11 \u6708 2 \u65e5\u52a8\u7269\u5065\u5eb7\u65b0\u95fb\u4e0e\u6ce8\u91ca"},"content":{"rendered":"<p><a target=\"_blank\" href=\"\/wp-content\/uploads\/2018\/01\/AHN_11-2-12.pdf\">\u6253\u5370\u7248\u672c<\/a><\/p>\n<p>***********************************<br \/>\n<strong>Brakke \u54a8\u8be2\u516c\u53f8\u7684 <br \/>\n2012 \u5e74 11 \u6708 2 \u65e5\u52a8\u7269\u5065\u5eb7\u65b0\u95fb\u4e0e\u6ce8\u91ca<br \/>\n<\/strong>\u7248\u6743\u6240\u6709 \u00a9 Brakke \u54a8\u8be2\u516c\u53f8<br \/>\n&nbsp;<br \/>\n\u7f16\u8f91\uff1aLynn Fondon DVM MBA<br \/>\n************************************<br \/>\n\u65b0\u95fb\u62a5\u9053\uff1a<br \/>\n&nbsp;<br \/>\n<u>Brakke \u65b0\u95fb<\/u><br \/>\n2012 \u5e74\u8df3\u86a4\u548c\u5fc3\u4e1d\u866b\u7814\u7a76<br \/>\n&nbsp;<br \/>\n<u>\u76c8\u5229\u65b0\u95fb<br \/>\n<\/u>\u62dc\u8033<br \/>\n\u4e18\u9675<br \/>\n\u8f89\u745e<br \/>\n\u7ef4\u6258\u55b9\u8bfa\u5c14<br \/>\n&nbsp;<br \/>\n<u>\u5176\u4ed6\u65b0\u95fb<br \/>\n<\/u>\u6bd4\u7f8e\u8fbe<br \/>\n\u585e\u74e6<br \/>\nHH \u8d1d\u514b<br \/>\nJBS \u8054\u5408\u52a8\u7269\u4fdd\u5065 II<br \/>\n\u6731\u6d1b\u514b\u65af<br \/>\n\u5ba0\u7269\u5e74\u9f84<br \/>\n\u8f89\u745e\uff08\u4ea8\u5fb7\u62c9\uff09<br \/>\n\u8f89\u745e\uff08\u65e5\u672c\uff09<br \/>\n\u65e0\u7ebf\u7535\u7cfb\u7edf<br \/>\nSparhawk \u5b9e\u9a8c\u5ba4<br \/>\n&nbsp;<br \/>\n***********************************<br \/>\n<strong>\u5e03\u62c9\u514b\u54a8\u8be2\u6709\u9650\u516c\u53f8<br \/>\n12 \u6708\u5373\u5c06\u63a8\u51fa\uff1a<br \/>\n\u7f8e\u56fd\u8df3\u86a4\u63a7\u5236\u548c\u5fc3\u4e1d\u866b\u5e02\u573a<br \/>\n2012 \u5e74\u66f4\u65b0<br \/>\n\u7acb\u5373\u8ba2\u8d2d\u4eab\u53d7\u65e9\u9e1f\u6298\u6263<br \/>\n<\/strong>&nbsp;<br \/>\nBrakke Consulting \u5373\u5c06\u53d1\u5e03\u6211\u4eec 2012 \u5e74\u5173\u4e8e\u7f8e\u56fd\u8df3\u86a4\u63a7\u5236\u548c\u5fc3\u4e1d\u866b\u5e02\u573a\u7684\u62a5\u544a\u3002\u8be5\u62a5\u544a\u5305\u542b\u6709\u5173\u7f8e\u56fd\u5c0f\u52a8\u7269\u6740\u866b\u5242\u5e02\u573a\u7684\u5b9d\u8d35\u4fe1\u606f\uff0c\u5305\u62ec\uff1a<br \/>\n&nbsp;\u2013 \u8ba8\u8bba\u975e\u4e13\u5229\u6c1f\u866b\u8148\u4ea7\u54c1\u7684\u5f71\u54cd<br \/>\n&nbsp;\u2013 \u517d\u533b\u548c\u975e\u5904\u65b9\u8df3\u86a4\u63a7\u5236\u5e02\u573a\u7684\u6982\u8ff0<br \/>\n&nbsp;\u2013 \u9886\u5148\u7684\u517d\u533b\u8df3\u86a4\u548c\u5fc3\u4e1d\u866b\u4ea7\u54c1\u7684\u4ea7\u54c1\u63cf\u8ff0\u3001\u4ef7\u683c\u548c\u9500\u552e<br \/>\n&nbsp;\u2013 2012 \u5e74\u5bf9 200 \u591a\u540d\u517d\u533b\u7684\u8c03\u67e5 <br \/>\n&nbsp;\u2013 2012 \u5e74\u5bf9 500 \u540d\u5ba0\u7269\u4e3b\u4eba\u7684\u8c03\u67e5<\/p>\n<p>\u5982\u679c\u5728 11 \u6708 20 \u65e5\u661f\u671f\u4e8c\u4e4b\u524d\u8ba2\u8d2d\uff0c\u7f8e\u56fd\u8df3\u86a4\u63a7\u5236\u548c\u5fc3\u4e1d\u866b\u5e02\u573a\u62a5\u544a\u7684\u8d2d\u4e70\u4ef7\u683c\u4e3a $6,995\uff0c\u5982\u679c\u5728\u8be5\u65e5\u671f\u4e4b\u540e\u8ba2\u8d2d\uff0c\u5219\u4ef7\u683c\u4e3a $7,500\u3002<\/p>\n<p>\u8bf7\u8054\u7cfb Lynn Fondon \u535a\u58eb\uff0c\u7535\u8bdd\uff1a(972) 243-4033\uff0c\u6216 <a href=\"mailto:lfondon@brakkeconsulting.com\">lfondon@brakkeconsulting.com<\/a>&nbsp; \u9884\u8ba2\u62a5\u544a\uff0c\u6216\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95ee\u6211\u4eec\u7684\u7f51\u7ad9<br \/>\n&nbsp;<br \/>\n<a href=\"http:\/\/www.BrakkeConsulting.com\">www.BrakkeConsulting.com<\/a> <br \/>\n&nbsp;<br \/>\n***********************************<br \/>\n\u516c\u53f8\u4e1a\u7ee9\u53d1\u5e03<br \/>\n&nbsp;<br \/>\n&gt; \u8f89\u745e\u516c\u53f8\u516c\u5e03\u4e86 2012 \u5e74\u7b2c\u4e09\u5b63\u5ea6\u7684\u8d22\u52a1\u4e1a\u7ee9\u3002\u52a8\u7269\u4fdd\u5065\u90e8\u95e8\u6536\u5165\u4e0b\u964d 2% \u81f3 $10.17 \u4ebf\u7f8e\u5143\u3002\u6392\u9664\u5916\u6c47\u5f71\u54cd\uff0c\u6536\u5165\u4e0e\u53bb\u5e74\u540c\u671f\u76f8\u6bd4\u589e\u957f 4%\u3002\uff08\u516c\u53f8\u7f51\u7ad9\uff09 <br \/>\n&nbsp;<br \/>\n&gt; \u62dc\u8033\u516c\u5e03\u4e86 2012 \u5e74\u7b2c\u4e09\u5b63\u5ea6\u7684\u4e1a\u7ee9\u3002\u52a8\u7269\u4fdd\u5065\u90e8\u95e8\u7684\u9500\u552e\u989d\u8fbe\u5230 3.4 \u4ebf\u6b27\u5143\uff08$4.39 \u4ebf\uff09\uff0c\u6bd4 2011 \u5e74\u7b2c\u4e09\u5b63\u5ea6\u589e\u957f 21%\uff08\u5916\u6c47\u548c\u6295\u8d44\u7ec4\u5408\u8c03\u6574\u540e\u4e3a +11%\uff09\u3002\uff08\u516c\u53f8\u7f51\u7ad9\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; Vetoquinol \u516c\u5e03\u4e86 2012 \u5e74\u524d 9 \u4e2a\u6708\u7684\u8d22\u52a1\u4e1a\u7ee9\u3002\u9500\u552e\u989d\u4e3a 2.21 \u4ebf\u6b27\u5143\uff08$2.86 \u4ebf\uff09\uff0c\u6bd4 2011 \u5e74\u540c\u671f\u589e\u957f 6%\u3002\uff08\u516c\u53f8\u7f51\u7ad9\uff09 <br \/>\n&nbsp;<br \/>\n&gt; \u9ad8\u9732\u6d01\u68d5\u6984\u516c\u53f8\u516c\u5e03\u4e86 2012 \u5e74\u7b2c\u4e09\u5b63\u5ea6\u7684\u4e1a\u7ee9\u30022012 \u5e74\u7b2c\u4e09\u5b63\u5ea6\uff0c\u9ad8\u9732\u6d01\u7684\u51c0\u9500\u552e\u989d\u4e0b\u964d\u4e86 1.5%\uff0c\u81f3 $5.28 \u4ebf\u3002\u9500\u91cf\u4e0b\u964d\u4e86 2.5%\uff0c\u5b9a\u4ef7\u4e0a\u6da8\u4e86 4.0%\uff0c\u5916\u6c47\u635f\u5931\u4e86 3.0%\u3002\uff08\u516c\u53f8\u7f51\u7ad9\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n************************************<br \/>\n\u516c\u53f8\u65b0\u95fb\u7a3f<br \/>\n&nbsp;<br \/>\n&gt; Ceva Sant\u00e9 Animale \u5ba3\u5e03\u5c06\u4ece\u6b27\u6d32\u9886\u5148\u7684\u79c1\u52df\u80a1\u6743\u516c\u53f8\u4e4b\u4e00 AXA Private Equity \u83b7\u5f97 1 \u4ebf\u6b27\u5143\uff08$1.3 \u4ebf\u6b27\u5143\uff09\u7684\u8d44\u91d1\u3002\u6b64\u6b21\u4ea4\u6613\u662f\u7ee7 AXA \u4e8e 2007 \u5e74\u5bf9 Ceva \u8fdb\u884c\u80a1\u6743\u6295\u8d44\u4e4b\u540e\u8fdb\u884c\u7684\uff0c\u5f53\u65f6 AXA \u63d0\u4f9b\u4e86 3000 \u4e07\u6b27\u5143\u7684\u8d44\u91d1\u3002Ceva \u8868\u793a\uff0c\u8fd9\u79cd\u7075\u6d3b\u7684\u503a\u5238\u878d\u8d44\u65b9\u5f0f\u5c06\u4f7f\u5176\u80fd\u591f\u8fdb\u5165\u4e0b\u4e00\u53d1\u5c55\u9636\u6bb5\u5e76\u5b9e\u65bd\u5176\u56fd\u9645\u5316\u5efa\u8bbe\u6218\u7565\u3002\uff08Animal Pharm\uff09 <br \/>\n&nbsp;<br \/>\n&gt; FDA \u5ba3\u5e03\u6279\u51c6 Jurox Pty \u7684 Alfaxan\uff08\u963f\u6cd5\u6c99\u9f99\uff09\u7684\u4e00\u9879\u65b0\u52a8\u7269\u836f\u7269\u7533\u8bf7\uff0c\u7528\u4e8e\u732b\u548c\u72d7\u7684\u9ebb\u9189\u8bf1\u5bfc\u548c\u7ef4\u6301\u4ee5\u53ca\u9ebb\u9189\u8bf1\u5bfc\u540e\u7528\u5438\u5165\u9ebb\u9189\u5242\u7ef4\u6301\u3002\uff08FDA\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; Bimeda \u5ba3\u5e03\u8be5\u516c\u53f8\u5df2\u83b7\u5f97 FDA \u6279\u51c6\u9500\u552e AmproMed P for Poultry\uff08\u5b89\u666e\u7f57\u5229\uff099.6% \u53e3\u670d\u6eb6\u6db2\u3002\u8fd9\u79cd\u6297\u7403\u866b\u836f\u9002\u7528\u4e8e\u6cbb\u7597\u751f\u957f\u9e21\u3001\u706b\u9e21\u548c\u4ea7\u86cb\u6bcd\u9e21\u7684\u7403\u866b\u75c5\u3002\uff08\u516c\u53f8\u65b0\u95fb\u7a3f\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; FDA \u5ba3\u5e03\u6279\u51c6 JBS United Animal Health II \u7684 OvuGel\uff08\u918b\u9178\u66f2\u666e\u745e\u6797\uff09\u7684\u65b0\u52a8\u7269\u836f\u7269\u7533\u8bf7\uff0c\u7528\u4e8e\u540c\u6b65\u65ad\u5976\u6bcd\u732a\u7684\u6388\u7cbe\u65f6\u95f4\uff0c\u4ee5\u4fbf\u4e8e\u5355\u6b21\u56fa\u5b9a\u65f6\u95f4\u7684\u4eba\u5de5\u6388\u7cbe\u3002\uff08FDA\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; FDA \u5ba3\u5e03\u6279\u51c6 Sparhawk Laboratories \u7684 SparMectin Plus Clorsulon\uff08\u4f0a\u7ef4\u83cc\u7d20\u548c\u6c2f\u8212\u9686\uff09\u7684\u7b80\u5316\u65b0\u52a8\u7269\u836f\u7269\u7533\u8bf7\uff0c\u7528\u4e8e\u6709\u6548\u6cbb\u7597\u548c\u63a7\u5236\u725b\u7684\u80c3\u80a0\u9053\u86d4\u866b\u3001\u80ba\u866b\u3001\u809d\u5438\u866b\u3001\u86f4\u87ac\u3001\u5438\u8671\u548c\u75a5\u87a8\u3002\uff08FDA\uff09&nbsp; <br \/>\n&nbsp;<br \/>\n&gt; \u62e5\u6709 PetSafe\u3001Invisible Fence \u548c Drinkwell \u7684 Radio Systems Corp \u5ba3\u5e03\u5c06\u5728\u7231\u5c14\u5170\u5f00\u8bbe\u6b27\u6d32\u603b\u90e8\u3002\uff08\u5ba0\u7269\u4ea7\u54c1\u65b0\u95fb\uff09 <br \/>\n&nbsp;<br \/>\n&gt; HH Backer \u5ba3\u5e03\u5df2\u5c06\u300a\u5ba0\u7269\u65f6\u4ee3\u300b\u6742\u5fd7\u51fa\u552e\u7ed9 Journal Multimedia\u3002Journal Multimedia \u4e3a\u5c0f\u4f17\u5e02\u573a\u5236\u4f5c\u5404\u79cd\u51fa\u7248\u7269\u3001\u6d3b\u52a8\u3001\u7f51\u7edc\u4ea7\u54c1\u3001\u89c6\u9891\u548c\u8f6f\u4ef6\u3002\u8d22\u52a1\u6761\u6b3e\u5c1a\u672a\u62ab\u9732\u3002\uff08\u5ba0\u7269\u4ea7\u54c1\u65b0\u95fb\uff09 <br \/>\n&nbsp;<br \/>\n&gt; \u6fb3\u5927\u5229\u4e9a \u8f89\u745e\u52a8\u7269\u4fdd\u5065\u516c\u53f8\u5ba3\u5e03\u5728\u6fb3\u5927\u5229\u4e9a\u63a8\u51fa Equivac HeV \u75ab\u82d7\uff0c\u8fd9\u662f\u4e00\u79cd\u9488\u5bf9\u4ea8\u5fb7\u62c9\u75c5\u6bd2\u7684\u9a6c\u7528\u75ab\u82d7\u3002\u8be5\u75ab\u82d7\u7531\u8f89\u745e\u4e0e\u6fb3\u5927\u5229\u4e9a\u548c\u7f8e\u56fd\u52a8\u7269\u4fdd\u5065\u5b9e\u9a8c\u5ba4\u5408\u4f5c\u5f00\u53d1\u3002\uff08Animal Pharm\uff09 <br \/>\n&nbsp;<br \/>\n&gt; \u65e5\u672c\u8f89\u745e\u52a8\u7269\u4fdd\u5065\u516c\u53f8\u5ba3\u5e03\u5728\u65e5\u672c\u5e02\u573a\u63a8\u51fa\u7528\u4e8e\u6cbb\u7597\u72ac\u7ec6\u83cc\u6027\u76ae\u80a4\u611f\u67d3\u7684 Simplicef \u7247\u5242\uff08\u5934\u5b62\u6cca\u809f\u916f\uff09\u3002\uff08Animal Pharm\uff09 <br \/>\n&nbsp;<br \/>\n***********************************<br \/>\n\u52a8\u7269\u5065\u5eb7\u65b0\u95fb<br \/>\n&nbsp;<br \/>\n&gt; \u7231\u5c14\u5170 \u2013 \u65bd\u9a6c\u4f26\u8d1d\u683c \u7231\u5c14\u5170\u5df2\u786e\u8ba4\u611f\u67d3\u65bd\u9a6c\u4f26\u8d1d\u683c\u75c5\u6bd2 (SBV)\uff0c\u8fd9\u662f\u8fc4\u4eca\u4e3a\u6b62\u53d1\u73b0\u611f\u67d3\u8be5\u75c5\u6bd2\u7684\u4e5d\u4e2a\u6b27\u6d32\u56fd\u5bb6\u4e2d\u6700\u897f\u7aef\u7684\u4e00\u4e2a\u3002\u7231\u5c14\u5170\u519c\u4e1a\u3001\u98df\u54c1\u548c\u6e14\u4e1a\u90e8\u6b63\u5728\u5f00\u5c55\u68c0\u6d4b\u4ee5\u786e\u5b9a\u611f\u67d3\u6e90\u3002\uff08Animal Pharm\uff09<br \/>\n&nbsp;<br \/>\n&gt; \u7f8e\u56fd \u2013 \u6d41\u611f \u4fc4\u4ea5\u4fc4\u5dde\u7acb\u5927\u5b66\u7814\u7a76\u4eba\u5458\u8fdb\u884c\u7684\u4e24\u9879\u7814\u7a76\u53d1\u73b0\uff0c\u4fc4\u4ea5\u4fc4\u5dde\u53bf\u96c6\u5e02\u4e0a\u8d85\u8fc7 80% \u7684\u732a\u6d41\u611f\u68c0\u6d4b\u5448\u9633\u6027\uff0c\u4f46\u65e0\u75c7\u72b6\uff0c\u4eba\u4e0e\u732a\u611f\u67d3\u4e86\u540c\u4e00\u79cd\u6d41\u611f\u75c5\u6bd2\u682a\u3002\u636e CDC \u79f0\uff0c\u81ea 7 \u6708\u4ee5\u6765\uff0c\u4fc4\u4ea5\u4fc4\u5dde\u5df2\u6709 107 \u4eba\u611f\u67d3 H3N2v\uff0c\u5176\u4e2d\u5927\u591a\u6570\u75c5\u4f8b\u4e0e\u96c6\u5e02\u4e0a\u7684\u732a\u63a5\u89e6\u6709\u5173\u3002\uff08AVMA SmartBrief \u2013 ScienceDaily\uff09<br \/>\n&nbsp;<br \/>\n&gt; \u7f8e\u56fd \u2013 \u9e21\u8089\u5e72\u96f6\u98df FDA \u62a5\u544a\u79f0\uff0c\u4e0e\u98df\u7528\u6765\u81ea\u4e2d\u56fd\u7684\u9e21\u8089\u5e72\u96f6\u98df\u6709\u5173\u7684\u5ba0\u7269\u60a3\u75c5\u6570\u91cf\u5df2\u4ece 1,800 \u8d77\u589e\u52a0\u5230 2,200 \u591a\u8d77\uff0c\u6b7b\u4ea1\u4eba\u6570\u4e5f\u4ece 300 \u4eba\u589e\u52a0\u5230 361 \u4eba\u3002\u5c3d\u7ba1\u8fdb\u884c\u4e86\u5e7f\u6cdb\u7684\u68c0\u6d4b\uff0c\u4f46\u75be\u75c5\u7684\u539f\u56e0\u4ecd\u672a\u67e5\u660e\u3002\uff08DVM \u65b0\u95fb\uff09<br \/>\n&nbsp;<br \/>\n***********************************<br \/>\nBRAKKE \u54a8\u8be2\u89c2\u70b9<\/p>\n<p>\u51e0\u5bb6\u9886\u5148\u7684\u52a8\u7269\u4fdd\u5065\u516c\u53f8\u53d1\u5e03\u7684\u7b2c\u4e09\u5b63\u5ea6\u8d22\u52a1\u62a5\u544a\u8868\u660e\uff0c\u73b0\u5728\u548c 2013 \u5e74\u9700\u8981\u8003\u8651\u7684\u4e00\u4e2a\u56e0\u7d20\u662f\u8d27\u5e01\u6c47\u7387\u53d8\u5316\u7684\u5f71\u54cd\u3002\u8d27\u5e01\u6c47\u7387\u901a\u5e38\u7531\u9996\u5e2d\u8d22\u52a1\u5b98\u5904\u7406\uff0c\u4f46\u8fdf\u65e9\u4f1a\u4ee5\u67d0\u79cd\u5f62\u5f0f\u5f71\u54cd\u5230\u8fd0\u8425\u548c\u8425\u9500\u7ba1\u7406\u3002\u8be5\u884c\u4e1a\u6b63\u53d8\u5f97\u8d8a\u6765\u8d8a\u5168\u7403\u5316\uff0c\u968f\u7740\u5c11\u6570\u5927\u578b\u8de8\u56fd\u516c\u53f8\u7684\u5e02\u573a\u4efd\u989d\u4e0d\u65ad\u589e\u52a0\uff0c\u6211\u4eec\u5f88\u53ef\u80fd\u5728\u672a\u6765\u770b\u5230\u66f4\u591a\u5173\u4e8e\u8d27\u5e01\u5bf9\u6536\u5165\u5f71\u54cd\u7684\u8ba8\u8bba\u3002 <br \/>\n&nbsp;<br \/>\n\u66f4\u4ee4\u4eba\u62c5\u5fe7\u7684\u662f\uff0c\u4e00\u4e9b\u516c\u53f8\u62a5\u544a\u79f0\u5355\u4f4d\u9500\u91cf\u4e0b\u964d\uff0c\u8fd9\u8868\u660e\u5ba0\u7269\u4e3b\u4eba\u548c\u5ba0\u7269\u751f\u4ea7\u5546\u7684\u4ea7\u54c1\u548c\u670d\u52a1\u4ef7\u683c\u4e0e\u4ef7\u503c\u5173\u7cfb\u53ef\u80fd\u8fbe\u5230\u9876\u5cf0\u3002\u770b\u6765 FDA \u5728\u65b0\u4ea7\u54c1\u5ba1\u6279\u65b9\u9762\u5ea6\u8fc7\u4e86\u5bcc\u6709\u6210\u6548\u7684\u4e00\u5468\u3002\u9700\u8981\u65b0\u4ea7\u54c1\u548c\u521b\u65b0\u6765\u652f\u6491\u6536\u5165\u589e\u957f\u7684\u538b\u529b\u3002<\/p>\n<p>\u6211\u4eec\u5411\u7f8e\u56fd\u4e1c\u5317\u90e8\u906d\u53d7\u5927\u81ea\u7136\u4e25\u91cd\u6253\u51fb\u7684\u5ba2\u6237\u548c\u670b\u53cb\u8868\u793a\u62c5\u5fe7\u548c\u7948\u7977\u3002\u6211\u4eec\u795d\u613f\u4f60\u4eec\u6bcf\u4e2a\u4eba\u90fd\u80fd\u4ece\u8fd9\u573a\u707e\u96be\u4e2d\u6062\u590d\u8fc7\u6765\u3002<\/p>\n<p>\u6709\u4e00\u4e2a\u7f8e\u597d\u7684\u5468\u672b\uff01\uff01 <br \/>\n&nbsp;<br \/>\n\u7f57\u6069\u00b7\u5e03\u62c9\u514b<br \/>\n&nbsp;<br \/>\n**********************************<br \/>\n\u672c\u7535\u5b50\u901a\u8baf\u5f52 Brakke Consulting, Inc. \u72ec\u6709\u3002<br \/>\n\u5bf9\u672c\u6587\u5185\u5bb9\u7684\u4efb\u4f55\u4f7f\u7528\u5747\u987b\u7ecf\u8fc7 Brakke Consulting, Inc. \u7684\u6279\u51c6\u5e76\u9002\u5f53\u6ce8\u660e\u6765\u6e90\u3002<br \/>\n\u6709\u5173 Brakke Consulting \u670d\u52a1\u548c\u8054\u5408\u7814\u7a76\u7684\u66f4\u591a\u4fe1\u606f\uff0c\u8bf7\u8bbf\u95ee\u6211\u4eec\u7684\u7f51\u7ad9 <a href=\"https:\/\/brakkeconsulting.com\/zh\/\">www.brakkeconsulting.com<\/a>.<br \/>\n&nbsp;<br \/>\nBrakke \u54a8\u8be2\u516c\u53f8<br \/>\n12005 \u798f\u7279\u8def\uff0c530 \u5ba4<br \/>\n\u7f8e\u56fd\u5fb7\u514b\u8428\u65af\u5dde\u8fbe\u62c9\u65af 75234<\/p>","protected":false},"excerpt":{"rendered":"<p>\u6253\u5370\u7248\u672c ************************************ Brakke Consulting 2012 \u5e74 11 \u6708 2 \u65e5\u7684\u52a8\u7269\u5065\u5eb7\u65b0\u95fb\u548c\u7b14\u8bb0 \u7248\u6743\u6240\u6709 \u00a9 Brakke Consulting, Inc. \u7f16\u8f91\uff1aLynn Fondon DVM MBA ************************************ \u65b0\u95fb\u62a5\u9053\uff1a Brakke \u65b0\u95fb 2012 \u5e74\u8df3\u86a4\u548c\u5fc3\u4e1d\u866b\u7814\u7a76\u6536\u76ca\u65b0\u95fb Bayer Hill&#039;s Pfizer Vetoquinol \u5176\u4ed6\u65b0\u95fb Bimeda Ceva HH Backer JBS United Animal Health II Jurox Pet Age Pfizer (Hendra) Pfizer (Japan) Radio Systems Sparhawk Labs ********************************** BRAKKE CONSULTING, INC. 12 \u6708\u5373\u5c06\u53d1\u5e03\uff1a\u7f8e\u56fd\u8df3\u86a4\u63a7\u5236\u548c\u5fc3\u4e1d\u866b\u5e02\u573a 2012 \u5e74\u66f4\u65b0 \u7acb\u5373\u8ba2\u8d2d\u53ef\u4eab\u53d7\u65e9\u9e1f\u6298\u6263 Brakke Consulting \u5373\u5c06\u53d1\u5e03\u6211\u4eec\u5173\u4e8e\u7f8e\u56fd\u8df3\u86a4\u63a7\u5236\u548c\u5fc3\u4e1d\u866b\u5e02\u573a\u7684 2012 \u5e74\u62a5\u544a\u3002\u8be5\u62a5\u544a\u5305\u542b\u6709\u5173\u7f8e\u56fd\u5c0f\u52a8\u7269\u5bc4\u751f\u866b\u9632\u6cbb\u5e02\u573a\u7684\u5b9d\u8d35\u4fe1\u606f\uff0c\u5305\u62ec\uff1a\u2013 \u975e\u4e13\u5229\u6c1f\u866b\u8148\u4ea7\u54c1\u7684\u5f71\u54cd\u63a2\u8ba8 \u2013 \u517d\u836f\u548c\u975e\u5904\u65b9\u8df3\u86a4\u63a7\u5236\u5e02\u573a\u6982\u51b5 \u2013 \u4e3b\u8981\u517d\u836f\u8df3\u86a4\u548c\u5fc3\u4e1d\u866b\u4ea7\u54c1\u7684\u63cf\u8ff0\u3001\u4ef7\u683c\u548c\u9500\u552e\u60c5\u51b5 \u2013 2012 \u5e74\u5bf9 200 \u591a\u540d\u517d\u533b\u7684\u8c03\u67e5 \u2013 2012 \u5e74\u5bf9 500 \u540d\u5ba0\u7269\u4e3b\u4eba\u7684\u8c03\u67e5\u3002\u8fd9\u4efd\u5173\u4e8e\u7f8e\u56fd\u8df3\u86a4\u63a7\u5236\u548c\u5fc3\u4e1d\u866b\u5e02\u573a\u7684\u62a5\u544a\u5c06\u4e8e 11 \u6708 20 \u65e5\uff08\u661f\u671f\u4e8c\uff09\u4e4b\u524d\u8ba2\u8d2d\uff0c\u552e\u4ef7\u4e3a $6,995 \u7f8e\u5143\uff0c\u4e4b\u540e\u8ba2\u8d2d\uff0c\u552e\u4ef7\u4e3a $7,500 \u7f8e\u5143\u3002\u8bf7\u8054\u7cfb Lynn Fondon \u535a\u58eb\uff0c\u7535\u8bdd (972) 243-4033 \u6216\u53d1\u9001\u7535\u5b50\u90ae\u4ef6\u81f3 lfondon@brakkeconsulting.com \u9884\u8ba2\u62a5\u544a\uff0c\u6216\u8bbf\u95ee\u6211\u4eec\u7684\u7f51\u7ad9\u4e86\u89e3\u66f4\u591a\u4fe1\u606f\u3002<\/p>\n<div class=\"view-full-post\"><a href=\"https:\/\/brakkeconsulting.com\/zh\/23828\/\" class=\"view-full-post-btn\">\u67e5\u770b\u5b8c\u6574\u6587\u7ae0<\/a><\/div>\n<p>;<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-23828","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/zh\/23828\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"printer friendly version *********************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for November 2, 2012 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: &nbsp; Brakke news 2012 flea &amp; heartworm study &nbsp; earnings news Bayer Hill&rsquo;s Pfizer Vetoquinol &nbsp; other news Bimeda Ceva H. H. Backer JBS United Animal Health II Jurox Pet Age Pfizer (Hendra) Pfizer (Japan) Radio Systems Sparhawk Labs &nbsp; *********************************** BRAKKE CONSULTING, INC. COMING IN DECEMBER: US FLEA CONTROL &amp; HEARTWORM MARKETS 2012 UPDATE ORDER NOW FOR EARLY-BIRD DISCOUNT &nbsp; Brakke Consulting will soon be publishing our 2012 report on the US Flea Control and Heartworm Markets. The report includes valuable information on the US market for small animal parasiticides including: &nbsp;&#8211; discussion of the impact of generic fipronil products &nbsp;&#8211; an overview of the veterinary and OTC flea control markets &nbsp;&#8211; Product descriptions, prices, and sales for the leading veterinary flea and heartworm products &nbsp;&#8211; 2012 survey of over 200 veterinarians &nbsp;&#8211; 2012 survey of 500 pet owners The report on the US Flea Control &amp; Heartworm Markets will be available for a purchase price of $6,995 if ordered by TUESDAY, NOVEMBER 20, and $7,500 after that date. Please contact Dr. Lynn Fondon at (972) 243-4033 or lfondon@brakkeconsulting.com&nbsp; to pre-order the report, or for more information visit ourView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/zh\/23828\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2012-11-02T18:51:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-04-14T07:08:37+00:00\" \/>\n<meta name=\"author\" content=\"Brakke Consulting\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u4f5c\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Brakke Consulting\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 \u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/23828\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/23828\/\"},\"author\":{\"name\":\"Brakke Consulting\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"headline\":\"Animal Health News &#038; Notes for November 2, 2012\",\"datePublished\":\"2012-11-02T18:51:17+00:00\",\"dateModified\":\"2018-04-14T07:08:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/23828\/\"},\"wordCount\":1204,\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/23828\/\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/23828\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#website\"},\"datePublished\":\"2012-11-02T18:51:17+00:00\",\"dateModified\":\"2018-04-14T07:08:37+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/23828\/#breadcrumb\"},\"inLanguage\":\"zh-Hans\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/zh\/23828\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/zh\/23828\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Animal Health News &#038; Notes for November 2, 2012\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-Hans\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6\",\"name\":\"Brakke Consulting\",\"url\":\"https:\/\/brakkeconsulting.com\/zh\/author\/i5ww2018\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u6765\u81ea Brakke Consulting \u7684\u65b0\u95fb","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/zh\/23828\/","og_locale":"zh_CN","og_type":"article","og_title":"News from Brakke Consulting","og_description":"printer friendly version *********************************** Brakke Consulting&rsquo;s Animal Health News &amp; Notes for November 2, 2012 Copyright &copy; Brakke Consulting, Inc. &nbsp; Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: &nbsp; Brakke news 2012 flea &amp; heartworm study &nbsp; earnings news Bayer Hill&rsquo;s Pfizer Vetoquinol &nbsp; other news Bimeda Ceva H. H. Backer JBS United Animal Health II Jurox Pet Age Pfizer (Hendra) Pfizer (Japan) Radio Systems Sparhawk Labs &nbsp; *********************************** BRAKKE CONSULTING, INC. COMING IN DECEMBER: US FLEA CONTROL &amp; HEARTWORM MARKETS 2012 UPDATE ORDER NOW FOR EARLY-BIRD DISCOUNT &nbsp; Brakke Consulting will soon be publishing our 2012 report on the US Flea Control and Heartworm Markets. The report includes valuable information on the US market for small animal parasiticides including: &nbsp;&#8211; discussion of the impact of generic fipronil products &nbsp;&#8211; an overview of the veterinary and OTC flea control markets &nbsp;&#8211; Product descriptions, prices, and sales for the leading veterinary flea and heartworm products &nbsp;&#8211; 2012 survey of over 200 veterinarians &nbsp;&#8211; 2012 survey of 500 pet owners The report on the US Flea Control &amp; Heartworm Markets will be available for a purchase price of $6,995 if ordered by TUESDAY, NOVEMBER 20, and $7,500 after that date. Please contact Dr. Lynn Fondon at (972) 243-4033 or lfondon@brakkeconsulting.com&nbsp; to pre-order the report, or for more information visit ourView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/zh\/23828\/","og_site_name":"Brakke Consulting Website","article_published_time":"2012-11-02T18:51:17+00:00","article_modified_time":"2018-04-14T07:08:37+00:00","author":"Brakke Consulting","twitter_card":"summary_large_image","twitter_misc":{"\u4f5c\u8005":"Brakke Consulting","\u9884\u8ba1\u9605\u8bfb\u65f6\u95f4":"6 \u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/zh\/23828\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/zh\/23828\/"},"author":{"name":"Brakke Consulting","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"headline":"Animal Health News &#038; Notes for November 2, 2012","datePublished":"2012-11-02T18:51:17+00:00","dateModified":"2018-04-14T07:08:37+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/zh\/23828\/"},"wordCount":1204,"articleSection":["Newsletter"],"inLanguage":"zh-Hans"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/zh\/23828\/","url":"https:\/\/brakkeconsulting.com\/zh\/23828\/","name":"\u6765\u81ea Brakke Consulting \u7684\u65b0\u95fb","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/#website"},"datePublished":"2012-11-02T18:51:17+00:00","dateModified":"2018-04-14T07:08:37+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/zh\/23828\/#breadcrumb"},"inLanguage":"zh-Hans","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/zh\/23828\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/zh\/23828\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Animal Health News &#038; Notes for November 2, 2012"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/#website","url":"https:\/\/brakkeconsulting.com\/","name":"Brakke\u54a8\u8be2\u7f51\u7ad9","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-Hans"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/a5d2c4b59040e54bfe8f4f41f77e04d6","name":"\u5e03\u62c9\u514b\u54a8\u8be2\u516c\u53f8","url":"https:\/\/brakkeconsulting.com\/zh\/author\/i5ww2018\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/23828","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/comments?post=23828"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/23828\/revisions"}],"predecessor-version":[{"id":25379,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/posts\/23828\/revisions\/25379"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/media?parent=23828"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/categories?post=23828"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/zh\/wp-json\/wp\/v2\/tags?post=23828"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}